These findings provide, for the first time, evidence about the properties of IL-36γ in the regulation of AT-chronic inflammation, emerging as a link between AT biology and the obesity-associated comorbidities. The gene discussed is IL36G; the disease is obesity due to melanocortin 4 receptor deficiency.